Evidence map›Paper›PMID 38074506›Full record

ArticleJHEP reports : innovation in hepatology2024

Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.

Jordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, Ana Barreira-Díaz, Raquel Domínguez-Hernández, Francisco Rodríguez-Frías, Magda Campins, Joan Colom, Miguel Angel Casado, Albert Blanco-Grau and 9 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary Care.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  13. Article
  14. Frontiers in public health · 2025
    Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Jordi LlanerasEmergency Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Juan Carlos Ruiz-CoboLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Ariadna Rando-SeguraMicrobiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Ana Barreira-DíazLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Raquel Domínguez-HernándezPharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
Francisco Rodríguez-FríasCIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Magda CampinsEpidemiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Joan ColomPublic Health Agency of Catalonia, Health Department, General Subdirection on Prevention, Control and Care on Addictions, HIV, STI and Viral Hepatitis, Barcelona, Spain.
Miguel Angel CasadoCIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Albert Blanco-GrauBiochemistry Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Juan BañaresLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Arnau MonforteInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Anna Falcó-RogetInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Lourdes RuízLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Beatriz MezaEmergency Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Tomàs PumarolaMicrobiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Mar Riveiro-BarcielaLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Rafael EstebanLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
María ButiLiver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Vall d'Hebron Hospital Universitari · ESInstituto de Salud Carlos III · ESPharmacoeconomics and Health Outcomes Research Iberia (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Many people with HCV and HBV infection are unaware of their condition, particularly at-risk and vulnerable populations who face barriers for screening and linkage to care. Emergency departments are often their only point of contact with the health system. Methods: This is a prospective study investigating HBsAg and HCV antibody testing, with reflex testing for HDV antibodies and HCV RNA, in adults attending an emergency department and requiring a blood test. Positive cases were linked to care. A cost-effectiveness analysis was performed. Results: From February 2020 to February 2022, a total of 17,560 individuals were screened. HBsAg was detected in 91 (0.5%), HCV RNA in 128 (0.7%), and HDV antibodies in two (0.01%) individuals. Nearly 40% of positive cases were unaware of their condition. Linkage to care was achieved in 42 of 56 HBsAg-positive and 45 of 69 HCV RNA-positive participants who were candidates for referral. HCV and HBV screening Conclusions: On emergency department screening for hepatitis B, C, and D in Barcelona, the prevalence of HBsAg was 0.5% and HCV RNA 0.7%, approximately threefold higher than that observed in the general population. This strategy diagnosed patients with active HCV infection and no risk factors, who would not have been screened according to the current recommendations. Screening and linkage to care of viral hepatitis is cost-effective in this setting. Impact and implications: We evaluated the performance and cost-effectiveness of a viral hepatitis screening programme implemented in an emergency department, which aimed to identify and link to care people living with hepatitis B and C. Our findings reveal a threefold higher prevalence of hepatitis B and C than in the general Spanish population, possibly attributable to the role of the emergency department as the main healthcare gateway for vulnerable populations, who have a higher prevalence of viral hepatitis. Risk factors for viral hepatitis could not be identified in most people living with hepatitis B and C attending the emergency department; hence, screening beyond risk factors should be considered in hepatitis detection strategies. Emergency department screening is cost-effective for hepatitis C and is a cost-saving strategy for hepatitis B in our setting. These data should inform future updates to clinical guidelines.

Indexed as

Cost-effectiveness analysisEmergency serviceHBVHCVHDVMass screening

Identifiers

PMID38074506
PMCPMC10698271
OpenAlexW4387580667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.